<DOC>
	<DOCNO>NCT00071747</DOCNO>
	<brief_summary>The objective study evaluate effectiveness market drug treatment schizophrenia , add-on therapy antipsychotic 12-week period . Subjects schizophrenia maintain stable dose antipsychotic fulfill screen entrance criterion assessment 1-7 day first visit confirm eligibility .</brief_summary>
	<brief_title>Clinical Study Of Schizophrenia Both Men Women</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Inclusion criterion : If female , must pregnant , must incapable conceive take step prevent conception . Diagnosis Schizophrenia Patients must take clozapine monotherapy atypical antipsychotic least 3 month prior study . Exclusion criterion : Patients currently take take antidepressant medication last month prior . Patients suicidal homicidal last 6 month . Patients history autistic disorder another pervasive developmental disorder Patients whose condition due direct physiological effect substance ( e.g . drug abuse , medication ) general medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>lamotrigine</keyword>
</DOC>